Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling Journal Article


Authors: Rai, A. J.; Kamath, R. M.; Gerald, W.; Fleisher, M.
Article Title: Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling
Abstract: The GeXP genetic analysis system allows for multiplexed detection and quantitation of up to 35 genes in 192 samples in a single analysis. The analytical procedure includes modified reverse transcription and PCR amplification, followed by capillary electrophoretic separation. RNA material from multiple sample types can be used, including blood, cell lines, and tissue material. This instrumentation has a lower limit of detection of <2 ng with a dynamic range greater than two orders of magnitude, as tested in this validation. Precision experiments demonstrate a within-run coefficient-of- variation (CV)∈=∈11.1% at 25 ng and 12.9% at 12.5 ng total RNA for the complete workflow and CV∈=∈4.8% at 25 ng and 6.7% at 12.5 ng levels for the GeXP analysis alone. The between-run precision for the entire workflow was determined to be 25% at 25 ng. We have devised an optimized protocol and use it to successfully identify a gene expression signature capable of discriminating prostate tumor and non-tumor tissue samples. We used a combination of multiplex gene panels to interrogate ~70 genes in our primary screen. Our results demonstrate that a subset of these genes can be used to separate normal and tumor prostate tissue samples. This protocol using the GeXP analyzer allows for a high-throughput, robust, and reproducible assessment of multiplexed gene expression analysis, and can be used for biomarker discovery to compare different sample groups. With a dynamic linear range and satisfactory precision, this technology holds promise for rapidly identifying gene expression signatures from multiplexed reactions of up to 35 genes in large numbers of samples with limited amounts of starting material. © 2008 Springer-Verlag.
Keywords: genetics; area under the curve; polymerase chain reaction; biomarkers; metabolism; reverse transcription polymerase chain reaction; genes; gene expression profiling; tumor markers, biological; pathology; tumor marker; prostatic neoplasms; rna; prostate; cell culture; messenger rna; reverse transcriptase polymerase chain reaction; tumors; rna, messenger; oligonucleotide array sequence analysis; prostate tumor; amplification; nucleic acids; bioactivity; transcription; area under curve; dna microarray; management; analytical validation; biomarker discovery; cancer biomarkers; gexp; multiplexed gene expression; multiplexing
Journal Title: Analytical and Bioanalytical Chemistry
Volume: 393
Issue: 5
ISSN: 1618-2642
Publisher: Springer Verlag  
Date Published: 2009-03-01
Start Page: 1505
End Page: 1511
Language: English
DOI: 10.1007/s00216-008-2436-7
PUBMED: 18958454
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 30 November 2010" - "CODEN: ABCNB" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William L Gerald
    375 Gerald
  2. Alex J Rai
    13 Rai
  3. Martin Fleisher
    312 Fleisher
  4. Rashmi Muralidhar Kamath
    1 Kamath